2013 annual financial data
Ernexa Therapeutics 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was 6.29%.
Operating income was -1,119,000 USD and net income was -1,053,000 USD.
Operating cash flow was 1,493,000 USD.
Get free Ernexa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,749,000 USD
- Operating income
- -1,119,000 USD
- Net income
- -1,053,000 USD
- Operating cash flow
- 1,493,000 USD